Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nanni

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|March 29, 2011
[The document of chemical risk assessment: experiences in small companies]G Sciarra, M C Aprea, D Cardelli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical modelsV Ambrosini, C Quarta, P L Zinzani, et al.
ESMO Open|May 8, 2024
A prospective study on the early evaluation of response to androgen receptor-targeted agents with <sup>11</sup>C-Choline, <sup>68</sup>Ga-PSMA, and <sup>18</sup>F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experienceV Mollica, A Marchetti, N Fraccascia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2008
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancerM A Pantaleo, M Nannini, A Maleddu, et al.
La Radiologia Medica|December 16, 2006
18F-FDG PET/CT in the assessment of carcinoma of unknown primary originV Ambrosini, C Nanni, D Rubello, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2015
Imaging biomarkers in prostate cancer: role of PET/CT and MRIM Picchio, P Mapelli, V Panebianco, et al.
Clinical and Experimental Medicine|February 20, 2009
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors modelM A Pantaleo, L Landuzzi, G Nicoletti, et al.
International Journal of Oncology|August 13, 2008
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of casesM A Pantaleo, M Nannini, E Lopci, et al.
American Journal of Infection Control|August 9, 2016
Control of an outbreak of postoperative bone mucormycosis: An intervention study of contiguous cohortsMarcelo S Chaves, Diego Franco, Juan C Nanni, et al.
British Journal of Cancer|July 22, 2004
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patientsP L Zinzani, S Fanti, G Battista, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia|March 29, 2011
[The document of chemical risk assessment: experiences in small companies]G Sciarra, M C Aprea, D Cardelli, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 20, 2010
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical modelsV Ambrosini, C Quarta, P L Zinzani, et al.
ESMO Open|May 8, 2024
A prospective study on the early evaluation of response to androgen receptor-targeted agents with <sup>11</sup>C-Choline, <sup>68</sup>Ga-PSMA, and <sup>18</sup>F-FACBC PET in metastatic castration-resistant prostate cancer: a single-center experienceV Mollica, A Marchetti, N Fraccascia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2008
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancerM A Pantaleo, M Nannini, A Maleddu, et al.
La Radiologia Medica|December 16, 2006
18F-FDG PET/CT in the assessment of carcinoma of unknown primary originV Ambrosini, C Nanni, D Rubello, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2015
Imaging biomarkers in prostate cancer: role of PET/CT and MRIM Picchio, P Mapelli, V Panebianco, et al.
Clinical and Experimental Medicine|February 20, 2009
Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors modelM A Pantaleo, L Landuzzi, G Nicoletti, et al.
International Journal of Oncology|August 13, 2008
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of casesM A Pantaleo, M Nannini, E Lopci, et al.
American Journal of Infection Control|August 9, 2016
Control of an outbreak of postoperative bone mucormycosis: An intervention study of contiguous cohortsMarcelo S Chaves, Diego Franco, Juan C Nanni, et al.
British Journal of Cancer|July 22, 2004
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patientsP L Zinzani, S Fanti, G Battista, et al.
Pageof 6